- Home
- TVTX vs HTFL Comparison
TVTX vs HTFL Comparison
Compare TVTX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- HTFL
- Stock Information
- Founded
- TVTX 2008
- HTFL 2007
- Country
- TVTX United States
- HTFL United States
- Employees
- TVTX N/A
- HTFL N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- HTFL
- Sector
- TVTX Health Care
- HTFL
- Exchange
- TVTX Nasdaq
- HTFL Nasdaq
- Market Cap
- TVTX 2.5B
- HTFL 2.8B
- IPO Year
- TVTX N/A
- HTFL 2025
- Fundamental
- Price
- TVTX $29.05
- HTFL $38.63
- Analyst Decision
- TVTX Strong Buy
- HTFL Strong Buy
- Analyst Count
- TVTX 15
- HTFL 4
- Target Price
- TVTX $34.86
- HTFL $37.00
- AVG Volume (30 Days)
- TVTX 1.8M
- HTFL 358.4K
- Earning Date
- TVTX 10-30-2025
- HTFL 11-12-2025
- Dividend Yield
- TVTX N/A
- HTFL N/A
- EPS Growth
- TVTX N/A
- HTFL N/A
- EPS
- TVTX N/A
- HTFL N/A
- Revenue
- TVTX $333,865,000.00
- HTFL $148,540,000.00
- Revenue This Year
- TVTX $83.23
- HTFL $34.51
- Revenue Next Year
- TVTX $41.49
- HTFL $24.58
- P/E Ratio
- TVTX N/A
- HTFL N/A
- Revenue Growth
- TVTX 87.94
- HTFL 44.32
- 52 Week Low
- TVTX $12.91
- HTFL $26.56
- 52 Week High
- TVTX $28.85
- HTFL $41.22
- Technical
- Relative Strength Index (RSI)
- TVTX 73.62
- HTFL N/A
- Support Level
- TVTX $26.79
- HTFL N/A
- Resistance Level
- TVTX $28.24
- HTFL N/A
- Average True Range (ATR)
- TVTX 1.02
- HTFL 0.00
- MACD
- TVTX -0.01
- HTFL 0.00
- Stochastic Oscillator
- TVTX 100.00
- HTFL 0.00
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.